Qritive
Entrepreneur First '17Singapore, SG · Founded 2017 · 4 known investors
Qritive develops AI-powered modules and a digital pathology workbench (Pantheon) that help pathologists identify, grade, and classify cancer, including prostate and colon cancer, lymph node metastasis, and biomarker analysis. Its hardware-agnostic tools integrate into existing digital pathology workflows and image management systems for laboratories and healthcare providers.
Founders & leadership
Qritive was founded in 2017 by Aneesh Sathe and Kaveh Taghipour.
Investors · 4
Frequently asked questions
- What does Qritive do?
- Qritive develops AI-powered modules and a digital pathology workbench (Pantheon) that help pathologists identify, grade, and classify cancer, including prostate and colon cancer, lymph node metastasis, and biomarker analysis. Its hardware-agnostic tools integrate into existing digital pathology workflows and image management systems for laboratories and healthcare providers.
- Who founded Qritive?
- Qritive was founded by Aneesh Sathe, Kaveh Taghipour in 2017.
- Who are Qritive's investors?
- Qritive's investors include Crane Venture Partners, Entrepreneur First, Exfinity Ventures, Pix Vine Capital.
- Where is Qritive headquartered?
- Qritive is headquartered in Singapore, SG.